What is the safest way to withdraw from Adderall (amphetamine and dextroamphetamine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Safe Withdrawal from Adderall (Amphetamine-Dextroamphetamine)

The safest way to withdraw from Adderall is through a gradual tapering schedule under medical supervision, typically reducing the dose by 25% weekly for short-term users, or more gradually over several weeks to months for long-term users. 1

Assessment Before Withdrawal

  • Use a validated, standardized assessment tool to evaluate the patient's current dependence level, documenting baseline symptoms and medication history, including duration of use and daily dose 1
  • Document the rationale for each dose reduction during the tapering process 1
  • Assess for risk factors that may complicate withdrawal, including concurrent use of other substances 2

Tapering Protocol

  • For short-term users (less than 3 months), reduce dose by approximately 25% weekly 1
  • For long-term users, implement a more gradual taper over several weeks to months, with smaller incremental reductions (10-15% every 2-4 weeks) 1
  • Use a standardized scoring system to assess withdrawal symptoms throughout the tapering process 1
  • If withdrawal symptoms become severe, temporarily pause the taper at the current dose until symptoms stabilize before continuing 1

Managing Withdrawal Symptoms

  • Common Adderall withdrawal symptoms include fatigue, depression, increased appetite, sleep disturbances, irritability, and drug cravings 3
  • More severe symptoms may include anxiety, agitation, and in some cases, suicidal ideation 4
  • Cardiovascular parameters should be monitored during withdrawal, as blood pressure and heart rate may fluctuate as the body adjusts to decreasing amphetamine levels 5

Adjunctive Treatments

  • Consider non-pharmacological interventions including:

    • Cognitive-behavioral therapy to address psychological dependence 1
    • Regular physical exercise to help manage mood symptoms and promote sleep 1
    • Relaxation techniques to manage anxiety symptoms 1
    • Adequate hydration and nutrition 1
  • For specific withdrawal symptoms, consider targeted pharmacological interventions:

    • For insomnia: short-term use of non-benzodiazepine sleep aids 1
    • For depression/fatigue: bupropion has shown some efficacy in managing psychostimulant withdrawal 6
    • For anxiety: mirtazapine may help with both anxiety and sleep disturbances 6

Patient Education

  • Educate patients about expected withdrawal symptoms and their typical timeline 1
  • Emphasize that withdrawal symptoms are temporary and will improve with time 1
  • Provide clear instructions on when to seek medical attention for severe symptoms 1

Special Considerations and Pitfalls

  • Avoid abrupt discontinuation, which can lead to severe withdrawal symptoms and increased risk of relapse 2
  • Be aware that some patients may experience persistent post-withdrawal disorders that require longer-term management 2
  • Recognize that withdrawal from psychostimulants like Adderall may be complicated by underlying conditions that were being treated (e.g., ADHD symptoms may re-emerge and need alternative management) 3
  • Monitor for signs of depression and suicidal ideation, which can occur during withdrawal 4
  • Document all symptoms and medication adjustments throughout the withdrawal process 1

Follow-up Care

  • Schedule regular follow-up appointments during the tapering process to monitor progress and adjust the plan as needed 1
  • Consider more frequent monitoring for patients with comorbid psychiatric conditions 1
  • Develop a long-term plan for managing any underlying conditions that were being treated with Adderall 3

References

Guideline

Managing Benzodiazepine Withdrawal

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Adderall® (amphetamine-dextroamphetamine) toxicity.

Topics in companion animal medicine, 2013

Research

Effect of amphetamines on blood pressure.

The Cochrane database of systematic reviews, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.